Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-16-001465

Options or other derivatives

  • Chief Medical Officer and SVP acquired 132,886 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Stromatt Scott C Chief Medical Officer and SVP 2016-08-03 Grant or award · Restricted Stock Unit +54,762 54,762 D
Stromatt Scott C Chief Medical Officer and SVP 2016-08-03 Grant or award · Restricted Stock Unit +78,124 78,124 D
Loading xslF345X03/stromatt_4.xml…